plozasiran sodium

plozasiran sodium (REDEMPLO) is an FDA-listed pharmaceutical active ingredient. Associated with Arrowhead Pharmaceuticals Ireland Limited. Route of administration: subcutaneous. Current US regulatory status: approved.

REDEMPLO is a marketed brand name for plozasiran sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

plozasiran sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.